Skin conditions are among the most common chronic welfare problems in dogs, with the itch-scratch cycle causing significant distress and requiring targeted multimodal management.
Chronic skin disease causes constant, debilitating pruritus that profoundly impairs quality of life. Dogs with poorly controlled atopy scratch, bite and rub continuously, cannot sleep normally and show behaviour changes reflecting their chronic discomfort. Modern targeted therapies have transformed management — IL-31 pathway inhibitors provide itch control that older corticosteroids could not match with better safety profiles. The welfare imperative to investigate and treat skin conditions aggressively rather than tolerating chronic itch as inevitable is supported by both evidence and compassion.